Tag: Multiple Sclerosis
Study of Daclizumab Yields Mixed Results in Multiple Sclerosis
Relapse rates with daclizumab were lower than with a standard therapy, but side effects were greater
Melatonin May Play a Role in Seasonal MS Relapses
Melatonin improves symptoms in mice and reduces levels of specific T cells
MS Disease Progression May Be Delayed by Smoking Cessation
Each additional year of smoking accelerates time to secondary progressive disease by 5 percent
Breastfeeding Tied to Reduced Risk of MS Relapse Postpartum
Protective effect seems to last only about as long as exclusive nursing does
Up’d Physical Activity Tied to Fewer Symptoms in Kids With MS
Children with MS less physically active than those with monophasic acquired demyelinating syndrome
Optical Coherence Tomography IDs Brain Atrophy in MS
Retinal atrophy mirrors whole-brain atrophy over time, as measured by optical coherence tomography
Moderate-Quality Evidence for Marijuana Rx for Pain, Spasticity
Review of 79 studies indicates only low-quality evidence for other conditions
Anxiety Independently Predicts Pain in Patients With MS
Research confirms high prevalence of pain, affecting more than half of those with multiple sclerosis
Cost of Multiple Sclerosis Rx Soaring, Even for Older Meds
No meds available for MS for less than $50,000 a year in U.S., researchers say
FDA: Generic Copaxone Approved for Multiple Sclerosis
FDA reviewed additional information to ensure generic is as safe and effective as brand-name drug
